توپيرامات تيڤع ٢٠٠ ملغ

País: Israel

Idioma: árabe

Fuente: Ministry of Health

Ingredientes activos:

TOPIRAMATE 200 MG

Disponible desde:

TEVA PHARMACEUTICAL INDUST.LTD

Código ATC:

N03AX11

formulario farmacéutico:

TABLETS

Vía de administración:

PER OS

Fabricado por:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupo terapéutico:

TOPIRAMATE

indicaciones terapéuticas:

Topiramate Teva is indicated as adjunctive therapy for adults and children aged 6 and above with partial onset seizures or generalized tonic-clonic seizures. Topiramate teva is also indicated in adults and children as adjunctive therapy for the treatment of seizures associated with Lennox-Gastaut syndrome . Topiramate Teva is indicated as monotherapy in patients with newly diagnosed epilepsy in adults and children aged 7 years and above or for conversion to monotherapy in patients with epilepsy.Topiramate Teva is indicated in adults for the prevention of migraines. The use of Topiramate Teva in the acute treatment of migraine has not been studied .

Fecha de autorización:

2011-08-01